Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocugen

0.7680
+0.02994.05%
Volume:2.56M
Turnover:1.96M
Market Cap:224.27M
PE:-3.85
High:0.7799
Open:0.7410
Low:0.7410
Close:0.7381
Loading ...

Ocugen Inc - to Complete Phase 1 Ocu200 Trial in Second Half of 2025

THOMSON REUTERS
·
18 Mar

Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of Ocu200—a Novel Fusion Protein for Diabetic Macular Edema

THOMSON REUTERS
·
18 Mar

Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema

GlobeNewswire
·
18 Mar

Ocugen Inc. Stock Rises 6.6%, Outperforms Market

Dow Jones
·
18 Mar

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
14 Mar

Ocugen Inc. Stock Sheds 5.9%, Underperforms Market

Dow Jones
·
14 Mar

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
12 Mar

Ocugen Inc. Stock Slips 8.8%, Underperforms Market

Dow Jones
·
11 Mar

Ocugen Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
08 Mar

Ocugen’s Strategic Advancements and Financial Stability Justify Buy Rating

TIPRANKS
·
08 Mar

Ocugen Is Maintained at Buy by Chardan Capital

Dow Jones
·
06 Mar

Chardan Capital Adjusts Ocugen Price Target to $7 From $6, Maintains Buy Rating

MT Newswires Live
·
06 Mar

Ocugen Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar

Ocugen’s Strategic BLA Submissions and Financial Position Support Buy Rating

TIPRANKS
·
06 Mar

Ocugen Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.
·
06 Mar

Ocugen Inc (OCGN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs

GuruFocus.com
·
06 Mar

Ocugen Inc. Navigates Uncertainty Amid Potential Shifts in U.S. Fiscal and Tax Policies

TIPRANKS
·
06 Mar

Ocugen Reports Progress in Gene Therapy Trials

TIPRANKS
·
06 Mar

Ocugen Inc Earnings Call: Strategic Gains Amid Financial Challenges

TIPRANKS
·
06 Mar

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
06 Mar